Cardio-Oncology

Cardio-oncology is a quickly developing field gone for limiting the impacts of cardiovascular bleakness and mortality in cancer survivors. To meet this point, patients are evaluated at standard to characterize their danger of cardio toxicity and after that pursued nearly amid and after chemotherapy to survey for early signs or manifestations of cardiovascular diseases. Cardiovascular imaging, and specifically, transthoracic echocardiography, assumes a fundamental job in the gauge appraisal and sequential follow-up of cardio-oncology patients. The goals of this paper are to survey the systems of cardio toxicity of a few regular chemotherapeutic specialists related with an expanded hazard for left ventricular systolic brokenness and to layout proposals in regards to the pattern appraisal and sequential line up of cardio-oncology patients with an attention on the role of echocardiography.

  • HER2-directed therapy
  • Vascular toxicities
  • Novel Targeted Therapies
  • Chemotherapy-related cardiac dysfunctions
  • Platinum-Based Chemotherapy Agents
  • Malignancy of the heart Targeting Tyrosine Kinases for Cancer Therapy
  • Radiation-Induced Heart Disease
  • Intra-cardiac tumor

Related Conference of Cardio-Oncology

November 25-26, 2019

2nd World Heart Rhythm Conference

MENA Plaza Hotel Albarsha Dubai, UAE

Cardio-Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in